Curaleaf Holdings (CURLF) Profit After Tax (2019 - 2026)
Curaleaf Holdings (CURLF) posted quarterly Profit After Tax of $69.8 million for Q1 2026, up 215.83% year-over-year from $22.1 million in Q1 2025, and up 202.31% quarter-over-quarter from -$68.2 million in Q4 2025.
Curaleaf Holdings (CURLF) Profit After Tax (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Profit After Tax history runs 8 years deep, the most recent figure standing at $69.8 million for Q1 2026.
- In Q1 2026, Profit After Tax rose 215.83% year-over-year to $69.8 million; the TTM figure through Mar 2026 stood at -$103.6 million (up 52.99% YoY), while the FY2025 annual figure was -$228.2 million, down 7.82% from the prior year.
- Profit After Tax for Q1 2026 stood at $69.8 million, up from -$68.2 million in the prior quarter.
- The five-year high for Profit After Tax was $69.8 million in Q1 2026, with the low at -$57.7 billion in Q4 2023.
- The 5-year median for Profit After Tax is -$51.6 million (2024), against an average of -$3.4 billion.
- The sharpest annual moves came in 2023 and 2026: Profit After Tax slumped 21841.85% in 2023, then soared 215.83% in 2026.
- Curaleaf Holdings' Profit After Tax stood at -$262.7 million in 2022, then plunged by 21841.85% to -$57.7 billion in 2023, then surged by 99.88% to -$67.2 million in 2024, then decreased by 1.56% to -$68.2 million in 2025, then jumped by 202.31% to $69.8 million in 2026.
- Business Quant data shows CURLF's Profit After Tax at $69.8 million in Q1 2026, -$68.2 million in Q4 2025, and -$54.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Curaleaf Holdings | 2.49 Bn | 2.39 Bn | 169.91 Mn | 12.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.51 Mn |
| Mar 31, 2026 | 69.78 Mn |
| Dec 31, 2025 | -68.21 Mn |
| Sep 30, 2025 | -54.55 Mn |
| Jun 30, 2025 | -50.60 Mn |
| Mar 31, 2025 | -60.25 Mn |
| Dec 31, 2024 | -67.17 Mn |
| Sep 30, 2024 | -44.35 Mn |
| Jun 30, 2024 | -48.55 Mn |
| Mar 31, 2024 | -51.58 Mn |
| Dec 31, 2023 | -57.65 Bn |
| Sep 30, 2023 | -67.81 Mn |
| Jun 30, 2023 | -66.59 Mn |
| Mar 31, 2023 | -43.88 Mn |
| Dec 31, 2022 | -262.75 Mn |
| Sep 30, 2022 | -41.42 Mn |
| Jun 30, 2022 | -17.26 Mn |
| Mar 31, 2022 | 14.55 Mn |
| Dec 31, 2021 | -75.50 Mn |
| Sep 30, 2021 | -56.89 Mn |